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A B S T R A C T
Objective: We describe epidemiological trends of human brucellosis in Germany over a 13 year period
based on national surveillance data.
Methods: We analyzed demographic, clinical, laboratory and exposure information of symptomatic
laboratory-confirmed brucellosis cases notified 2006–18. Using official population data, we calculated
incidences and risk ratios (RR).
Results: From 2006 to 2018, 408 brucellosis cases were notified in Germany (mean annual incidence:
0.38/1,000,000 population), of which 75% were travel-associated. Yearly notifications peaked in 2014 (n =
47) and remained elevated compared to 2006–2013 (mean: n = 25). Asylum seekers (AS) arriving in
Germany accounted for 9/44 (2015) and 15/36 (2016) cases, respectively. RR AS/non-AS 2015–2016: 28,
95% CI: 17–45. Unpasteurized milk products were most frequently notified as source of infection.
Imported food and occupational exposure played a role in autochthonous cases.
Conclusions: The incidence of human brucellosis has markedly increased in recent years. Most of the
observed rise in notifications can be explained by infections in AS. Exposure still predominantly occurs
abroad. Risk factors for autochthonous infections need to be investigated further, though imported dairy
products seem to play a role. Physicians should consider brucellosis as differential diagnosis in AS and
people with travel to endemic regions with compatible symptoms.
© 2020 The Author(s). Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).
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Brucellosis is one of the most prevalent zoonoses worldwide
caused by infection with gram-negative bacteria of the genus
Brucella. The Mediterranean Basin, the Arabic peninsula, central
Asia, India, Africaand certain countries in centraland South America
are considered high-prevalence regions (Pappas et al., 2006).
The three most common species causing brucellosis in humans
are Brucella (B.) melitensis (main reservoir: goats and sheep), B.
abortus (main reservoir: cattle/other bovidae) and B. suis (main
reservoir: pigs).
Human exposure mainly occurs through direct contact with
infected animals, consumption of contaminated food (especially
unpasteurized milk products) or inhalation of contagious aerosols
(Mandell et al., 2010). Typical symptoms include fever, weight loss,
night sweats, arthralgia and headache that can persist for weeks to* Corresponding author.
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).months without appropriate antimicrobial treatment (Heymann,
2008). Every organ system can be affected and—although rare—
severe manifestations like neurobrucellosis or endocarditis can
occur (Dean et al., 2012; Pappas et al., 2005). However,
approximately 90% of infections remain subclinical. Delay of
diagnosis (and therefore treatment) is common due to the
unspecific nature of symptoms and is associated with a higher
complication rate (Colmenero et al., 1996).
Brucellosis is notifiable according to the German Protection
against Infection Act. It was endemic in Germany until the 1980s,
mainly affecting people with close contact to cattle (Al Dahouk
et al., 2007). In 2000, after successful implementation of control
measures, Germany was declared “officially free of bovine, ovine
and caprine brucellosis” (Godfroid and Kasbohrer, 2002).
Since then human cases have decreased considerably, and today
brucellosis is mostly associated with travel to endemic regions.
Enhanced surveillance 1995–2000 has identified Turkish migrants
as a high-risk group for brucellosis in Germany (Al Dahouk et al.,
2007).
Contrary to trends in many other European countries,
notifications in Germany sharply increased in 2014 and haveciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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national surveillance data we describe trends, risk groups and
factors associated with brucellosis in Germany 2006–2018.
Methods
Symptomatic brucellosis with laboratory confirmation is
notifiable by laboratories to the local public health office of the
case’s district of residence. There, case information is completed
and verified according to the surveillance case definition and then
transmitted to the state public health office in anonymized form.
From there it is forwarded to the national public health institute.
We analyzed cases of human brucellosis notified according to
the national surveillance case definition (see Box 1) between
01.01.2006 and 31.12.2018 in Germany.
We analyzed demographic, clinical, laboratory and relevant
exposure information coded in the case notification or transmitted
as free text.
We calculated the time between onset of symptoms and
notification to estimate diagnostic delay and extracted deaths
attributed to brucellosis from the mortality statistic of the
Information System of the Federal Health Monitoring to calculate
case-fatality rates.
We used figures from the Federal Office for Migration and
Refugees and the Federal Office of Statistics to calculate incidences
by time and place and calculated risk ratios (RR) and 95%
confidence intervals (95%-CI) comparing brucellosis incidences
in asylum seekers (AS) and non-AS.
Stata 15.1 (StataCorp, College Station, Texas, United States) was
used to carry out statistical analysis and Regiograph Analyse 16.0
(GfK SE, Nürnberg, Germany) to create maps on district level.Box 1. Germany’s national surveillance case definition for
human brucellosis
A case of brucellosis is defined as a person meeting the
clinical criteria with laboratory
AND/OR epidemiological confirmation.






Laboratory confirmation defined as at least 1 of the
following 3:
 cultural isolation
 detection of nucleic acids
 antibodies against Brucella species
Epidemiological confirmation defined as at least 1 of the
following 3:
 contact with a laboratory confirmed animal or its
products
 consumption of a contaminated food product
 contact with a laboratory confirmed human with whom a
common source was shared
Exclusion criterion: clinical signs >12 months at the time of
diagnosisResults
Time trends and seasonality
From 2006 to 2018, 408 cases of human brucellosis fulfilling the
case definition were notified in Germany, corresponding to a mean
annual incidence of 0.38/1,000,000 population (range: 0.22
(2009)–0.58 (2014)).
B. melitensis was the most commonly isolated species (n = 180/
197 with information, 91%), followed by B. abortus (n = 16, 8.1%) and
B. suis (n = 1, 0.5%).
Between 2007 and 2013 annual notifications ranged from 18 to
28, then markedly increased to 47 in 2014. Since then, notifications
have slightly decreased, but have remained above the levels
observed prior to 2014 (range 2015–2018: 36–44) (see Figure 1).
Onset of symptoms was reported in all months with a peak in
June/July (n = 76/319 with information, 24%).
Demographic characteristics
Cases occurred in all age groups, and overall both sexes were
equally affected (51% male) with the highest age-specific incidence
in women aged 60–69 (mean annual incidence 0.62/1,000,000
population) and the lowest in children under 10 years (both sexes:
0.16/1,000,000 population) (see Figure 2).
Coinciding with the increase in notifications, median age
decreased (41 versus 50 years, p = 0.001) and proportion of males
increased (44% (2006–2013) versus 58% (2014–2018), p = 0.008).
The mean annual incidence among males aged 10–49 years
2015–2017 was 1/1,000,000 population.
In 2014–2018, 36 cases occurred in known AS, including 7
children. Compared to non-AS, AS were significantly younger
(median age 29 versus 47 years, p < 0.0001) and proportion of
males among cases was higher (69% versus 49%, p = 0.02). In 2015,
20% and in 2016 42% of all notified brucellosis cases occurred
among AS. Comparing incidences among AS and non-AS 2015–
2016, AS had a 28-times higher risk of notified brucellosis (RR: 28,
95%-CI: 17–45).
Likely place and route of infection
Imported cases (exposure outside Germany)
Of 371 cases with information on place of exposure, 75% (n =
277, 288 entries) reported foreign travel prior to illness; most
commonly to the Middle East including Turkey (n = 182), followed
by Europe (n = 55), Asia excluding the Middle East (n = 21) and
Africa (n = 18). Middle/South America was named twice, Australia
once. For 5 cases the travel destination was not specified.
Most cases were exposed in Turkey (n = 115), followed by Iraq (n
= 23), Syria (n = 21), Italy (n = 13), Spain (n = 11), Egypt (n = 7),
Lebanon (n = 6), Greece (n = 5) and Iran (n = 5).
Except for a peak in 2014, the proportion of cases exposed in
Turkey decreased over time, reaching the lowest point in 2016 (n = 2)Figure 1. Number of notified human brucellosis cases by year of notification and
asylum seeker status (*systematically recorded since September 2015), Germany,
2006–2018.
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10) (see Figure 3).
In 2015, Middle East countries other than Turkey became the
most important region of exposure, mainly due to cases among
newly arriving AS from Syria and Iraq, but were superceded again
by Turkey in 2018. European countries have been increasingly
reported as place of exposure since 2017 and reached the highest
number in the study period in 2018 (n = 9, range 2006–2017: 2–6).
Type of travel was not routinely recorded, but information was
available for 69 (25%) cases: 31 were migrating AS, 28 stayed with
locals (visiting friends and relatives (VFR, n = 26), host family (n =
1), nomads (n = 1)), two were backpacking/hiking and eight were
on holidays in hotels and travel groups. For an additional 22 (8%)
cases a non-German nationality or a significant language barrier
was reported.
Median travel duration was 5 weeks (range 0.4-60 weeks,
available for n = 138) and was significantly longer in cases that
travelled to Turkey (7 weeks, p = 0.002, available for n = 69).
For 136 (49%) cases at least one likely source of infection was
identified in addition to foreign travel. 104 had consumed
unpasteurized milk products. Cheese (75 entries) most commonly
originated from Turkey (n = 39), Italy (n = 5), Iraq (n = 4), Portugal (n
= 4) and Spain (n = 3). Milk (49 entries) most commonly originated
from Turkey (n = 18), Iraq (n = 4), Lebanon (n = 4), Syria and Saudi
Arabia (each n = 3). All 3 cases exposed in Saudi-Arabia with
information had consumed camel milk. 47 cases had contact to
livestock (especially sheep, goats), of these two mentioned
participating in ritual slaughtering in Turkey. 11 cases had
consumed or prepared “fresh” meat (mainly lamb). 26 travel-
associated cases occurred in clusters with a maximum of 5 cases;
18 reported consumption of unpasteurized dairy products during
travel.
Autochthonous cases (exposure in Germany)
Of 94 cases that reportedly acquired brucellosis in Germany, 29
(31%) indicated at least one likely source of infection. Twelve casesFigure 3. Imported cases of brucellosis by year of notification, region of exposure (%) and
(n = 277).had consumed imported food (all 10 with information: unpasteur-
ized cheese from Iraq, Italy, Turkey), including one AS that had
arrived in Germany more than a year before symptom onset.
Imported cheese led to two clusters with a total of five reported
autochthonous infections. Three cases had consumed unpasteur-
ized cheese purchased in Germany; for two this was the only
identified source of infection. Eleven cases were occupationally
exposed; most commonly laboratory workers (n = 6, most recently
in 2015), but also military personnel (n = 2), a veterinarian (n = 1), a
butcher (n = 1) and an abattoir worker (n = 1). Six cases reported
non-occupational contact to livestock: sheep (n = 3), cattle (n = 2),
pigs and game through hunting (n = 1). The single identified B. suis
infection was acquired in rural Germany.
Place of exposure unknown
Of 37 cases with unknown place of exposure, 30 were notified
since 2014. Three were AS that had reached Germany in 2015 and
were diagnosed with brucellosis in 2017, but symptom onset was
unknown. At least one likely source of infection was identified for
13 (39%) cases, most commonly consumption of unpasteurized
milk products (n = 10, 6/7 with information from abroad). One case
had received a blood transfusion in Iraq in previous years.
Regional variation
All states in Germany reported at least one human brucellosis
case between 2006 and 2018. The highest mean annual incidences
in 2006–2018 were observed in the city-states Hamburg (0.78/
1,000,000 population) and Berlin (0.66/1,000,000 population).
Higher mean annual incidences in 2006-2018 were observed in
“Old West German states” including Berlin, where the proportion
of inhabitants with foreign nationality is also markedly higher
(0.42 vs 0.17/1,000,000 population in “New German states”, RR:
2.5, 95%-CI: 1.7–3.7) (see Figure 4).
Clinical information
Fever was the most commonly reported symptom (n = 343,
84%), followed by arthralgia and exhaustion (each n = 202, 50%),
headache (n = 148, 36%), loss of appetite (n = 131, 32%), night
sweats (n = 109, 27%) and other symptoms (n = 68, 17%). Other
symptoms (specified for n = 29) affected a variety of organ systems,
most commonly the gastrointestinal tract (n = 10) and the spine (n
= 9). Neurobrucellosis was reported for three and endocarditis for
one case. Of 393 cases with information, 272 (69%) were
hospitalized.
Comparing infection with B. abortus and B. meltitensis and
adjusting for age and sex, B. melitensis infection was associated asylum seeker status (*systematically recorded since September 2015), 2006–2018
Figure 4. Notified cases of brucellosis by district of residence (dots) and proportion of foreign nationals* within the population, 2006–2018 (shades).
*Defined as a people without German nationality.
**As of 31.12.2018, according to data from the German Federal Statistical Office (DESTATIS Statistisches Bundesamt, 2019).
***Dots randomly positioned in district of notification.
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4.1, 95%-CI: 1.3–12.5) while B. abortus infection was associated with
arthralgia (OR: 3.3, 95%-CI: 1.03–10.8).
The mean time between symptom onset and notification (proxy
for diagnostic delay) was 7.5 weeks (available for n = 311, median:
4, range: 0–65). It was significantly longer in females (mean 8.8
versus 6.4 weeks, p = 0.004) and in cases exposed abroad (mean 8.1
versus 7.3 weeks if autochthonous, p = 0.02) and significantly
shorter in cases among the often overlapping groups of AS (mean
4.5 versus 7.8 weeks, p = 0.01), cases with exposure in Middle East
countries other than Turkey (mean 5.3 versus 8.9 weeks, p =
0.0005), and hospitalized cases (mean 6.5 versus 9.9 weeks, p =
0.008).
While no death due to brucellosis was notified through national
surveillance, 13 deaths were attributed to brucellosis in the
mortality statistic of the Information System of the Federal Health
Monitoring 2006–2016 (data for 2018 not yet available). Using
notified cases as the denominator, this would indicate a case-
fatality-rate in 2006–2017 of 3.5% (95%-CI: 1.6–5.4). This result
needs to be interpreted with caution as there is no accounting forunderreporting of brucellosis and figures were extracted from two
different data-sources that could not be matched.
Discussion
We found a marked increase in brucellosis notifications in
Germany since 2014. The majority of cases were associated with
foreign travel, with indications that VFR-travel might play an
important role. The most commonly identified source of infection
was consumption of unpasteurized milk products. Fever was the
most frequently reported symptom and a high proportion of
patients were hospitalized. Most infections were caused by B.
melitensis. Mean duration between onset of symptoms and
notification was 7.5 weeks. For the majority of autochthonous
infections no source of infection was recorded; consumption of
imported milk products and occupational exposure were the most
commonly mentioned, but locally purchased cheese was also
reported.
Cases among newly arriving AS contributed to the observed
increase and explained all excess notifications in 2016 and most
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systematically collected since September 2015. The highest
increase in brucellosis notifications was observed in young males,
most commonly with exposure in Syria and Iraq. Armed conflicts in
the Middle East have led to displacement of people and migration
to other countries. Between 2014 and 2017 the Federal Office for
Migration and Refugees recorded 1.8 million arriving AS in
Germany. Most first time applicants for asylum were young males
(66% male, 83% <35 years) that had migrated from Syria,
Afghanistan and Iraq (BAMF, 2014, 2015, 2016, 2017), countries
with high brucellosis prevalence (OIE, 2019; Pappas et al., 2006;
Yacoub et al., 2006).
Reasons for the notification peak in 2014 are not fully
understood. Despite overall decreasing numbers of cases exposed
in Turkey since 2006 and a 50% reduction of annual brucellosis
cases in Turkey since the introduction of a new eradication
program for animal brucellosis in 2009 (Gul et al., 2014), compared
to 2013, the number of cases with exposure in Turkey in 2014
almost tripled and contributed substantially to the peak. This can
be partially explained by two clusters associated with consump-
tion of unpasteurized milk products in Turkey. Additionally, a
higher proportion of males and a younger age of cases ex-Turkey
2014 compared to 2006–2013 support the possibility that
migration of AS through Turkey may have contributed already.
Despite a substantial decrease of migration to Germany,
brucellosis notifications remained high in 2017–2018. Interesting-
ly, two of three AS with notified brucellosis in 2017 had already
been in Germany for more than 12 months, suggesting either
diagnosis or reporting was severely delayed or infection was
acquired in Germany. Imported food was the suspected source in
one case, which could indicate that AS living in Germany
potentially remain at higher risk for brucellosis after migration.
This has been previously observed among Turkish immigrants in
Germany, the Hispanic population in the U.S., immigrants from
Middle East countries in Denmark and the UK, and immigrants in
Spain with VFR-travel, and in the absence of travel importation of
food products from their home countries being continued risk
factors (Al Dahouk et al., 2007; Brough et al., 2011; Eckman, 1975;
Eriksen et al., 2002; Norman et al., 2016). As in previous German
studies (Al Dahouk et al., 2007), current data indicate that
brucellosis often affected VFR-travelers (reported or suggested
by long travel duration), that are more likely to live as part of the
local community and are also at higher risk for many other travel-
associated infections (Angell and Cetron, 2005; Health Protection
Agency, 2008; Leder et al., 2006). Few cases among non-VFR
travelers were also reported, but as the type of travel was not
systematically captured, these results have to be interpreted with
caution.
Since 2017 cases exposed in Turkey have increased again,
mirroring changes in travel patterns and local brucellosis
epidemiology. OIE reported annual brucellosis cases in Turkey
have increased again each year after the lowest recorded level in
2015 (OIE, 2019). At the same time air travel from Germany to
Turkey has picked up again in 2018 and further in 2019, after it had
slumped due to political unrest in 2016 (DESTATIS Statistisches
Bundesamt, 2020).
A specific source of infection was only reported for 45% of cases;
it was particularly low if brucellosis was acquired in Germany.
While laboratory workers in Germany were still occasionally
infected with brucellosis, the last case was reported in 2015. In
recent years, imported food (especially unpasteurized cheese) was
the most commonly mentioned source in autochthonous brucel-
losis and led to two small clusters in Germany. It is estimated that
more than 2,800 tons of illegal food products from non-EU
countries reach Germany every year via Frankfurt airport alone. A
study found Brucella-DNA in 3.6% of all confiscated food at Germanairports; in 7% if food originated from Turkey. As only a small
subset of passengers is subject to luggage inspection and individual
travellers are often carrying large quantities, it has to be assumed
that “illegal imports” contribute to infections in Germany (Beutlich
et al., 2015). To investigate the potential threat of cheese bought in
Germany, 200 cheese samples purchased online and on markets in
Berlin were microbiologically tested. Although no viable Brucellae
were detected using classical culture methods (which are
inherently difficult and often unsuccessful), 20.5% were Brucel-
la-DNA positive and 7% of those were produced from raw milk with
a short ripening period, potentially posing an infection risk (Jansen
et al., 2019). The authors suspected organized trade of illegal
imports from brucellosis endemic countries, stating often false
information was provided to customers. Whole genome sequenc-
ing (WGS) was recently described as a useful tool for “trace-back
analysis of B. melitensis suggesting the potential geographic origin
of the strain” (Georgi et al., 2017).
While B. melitensis today is the most commonly identified
species in human cases as well as in surveyed food items, more
exotic species may also play a role: The only notified human case
due to B. suis was initially misidentified as B. melitensis by MALDI-
TOF due to a lack of B. suis spectra in the database (Zange et al.,
2019). The patient had not travelled abroad and was living in a rural
area. While B. suis biovar 2 is occasionally detected in domestic pigs
and wild boars and hares in Germany (Friedrich-Loeffler-Insitut,
2018; LGL, 2018; Melzer et al., 2006), this human case was caused
by B. suis biovar 1 with closest proximity to strains originating from
Argentina. Investigations revealed infection might have been
acquired through imported meat (Zange et al., 2019).
Patients infected with B. abortus more commonly reported
arthralgia. This was also observed in studies in Turkey and USA.
While the Turkish study found no evidence suggesting that B.
melitensis was more virulent than B. abortus, the American study
reported B. melitensis “presented more acutely as fevers of
unknown origin” (Dokuzoguz et al., 2005; Troy et al., 2005).
Limitations
Underreporting has to be assumed: cases that remained
undiagnosed, were not reported or did not fulfill the case definition
were not considered in this analysis. Only clinical symptoms
included in the case definition were systematically collected,
leading to underestimation of other symptoms. Typical compli-
cations and treatment outcome were not captured, so we cannot
comment on those or the association of diagnostic delay and
unfavorable outcomes. Results on exposure can—in the absence of
control groups—only indicate possible risk factors. As the exact
number of AS was unknown, we used the highest available
estimation to avoid overestimation of RRs.
Conclusions and recommendations
In the study period brucellosis notifications increased and
epidemiology in Germany has changed in response to migration
from brucellosis endemic countries, change in travel patterns and
changing brucellosis epidemiology in countries that are frequently
visited by people living in Germany. Although it is rare in Germany,
physicians should consider brucellosis as a relevant differential
diagnosis in AS and people with travel to endemic regions with
compatible symptoms to reduce diagnostic delay and complica-
tions. Physicians should inform the laboratory if they suspect
brucellosis, so that protective measures can be taken to prevent
occupational infections. People travelling to endemic countries
(especially VFR-travelers) should be advised about risk factors for
and symptoms of the disease. As it is known that VFR-travelers
often do not seek travel advice, opportunistic inquiry about travel
358 J. Enkelmann et al. / International Journal of Infectious Diseases 93 (2020) 353–358plans and information during routine medical visits have been
suggested by some authors. In patients without foreign travel,
physicians and public health officers should inquire about
consumption of imported meat and unpasteurized milk products.
If identified as a potential source, other people that might have
been exposed should be included in the investigation.
Imported milk products seem to play a role in autochthonous
brucellosis, but risk factors in the absence of travel are
incompletely understood and need to be investigated further.
WGS may provide valuable information on the probable origin of
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